SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. You have free access to this content1
    Kristopher P. Croome, Dan Segal, Roberto Hernandez-Alejandro, Paul C. Adams, Alan Thomson, Natasha Chandok, Female donor to male recipient gender discordance results in inferior graft survival: a prospective study of 1,042 liver transplants, Journal of Hepato-Biliary-Pancreatic Sciences, 2014, 21, 4
  2. 2
    J. Howell, P. Angus, P. Gow, Hepatitis C recurrence: the Achilles heel of liver transplantation, Transplant Infectious Disease, 2014, 16, 1
  3. 3
    Shunji Nagai, Atsushi Yoshida, Keisuke Kohno, David Altshuler, Mio Nakamura, Kimberly A. Brown, Marwan S. Abouljoud, Dilip Moonka, Peritransplant absolute lymphocyte count as a predictive factor for advanced recurrence of hepatitis C after liver transplantation, Hepatology, 2014, 59, 1
  4. 4
    Deepak Joshi, Massimo Pinzani, Ivana Carey, Kosh Agarwal, Recurrent HCV after liver transplantation—mechanisms, assessment and therapy, Nature Reviews Gastroenterology and Hepatology, 2014, 11, 12, 710

    CrossRef

  5. 5
    Anthony J. Michaels, Renumathy Dhanasekaran, David P. Foley, Ahmad Alkhasawneh, Lisa Dixon, Consuelo Soldevila-Pico, Giuseppe Morelli, Roniel Cabrera, Virginia C. Clark, Roberto J. Firpi, Hepatic Preservation Injury: Severity of Hepatitis C Recurrence and Survival After Liver Transplantation, Digestive Diseases and Sciences, 2013, 58, 5, 1403

    CrossRef

  6. 6
    S. Akbulut, M. Wojcicki, C. Kayaalp, S. Yilmaz, Liver Transplantation With Piggyback Anastomosis Using a Linear Stapler: A Case Report, Transplantation Proceedings, 2013, 45, 3, 1031

    CrossRef

  7. 7
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Living-Donor Liver Transplantation and Hepatitis C, HPB Surgery, 2013, 2013, 1

    CrossRef

  8. 8
    Nobuhisa Akamatsu, Yasuhiko Sugawara, Liver Transplantation and Hepatitis C, International Journal of Hepatology, 2012, 2012, 1

    CrossRef

  9. 9
    T. Uemura, V. Ramprasad, C. S. Hollenbeak, D. Bezinover, Z. Kadry, Liver Transplantation for Hepatitis C From Donation After Cardiac Death Donors: An Analysis of OPTN/UNOS Data, American Journal of Transplantation, 2012, 12, 4
  10. 10
    Diethard Monbaliu, Jacques Pirenne, David Talbot, Liver transplantation using Donation after Cardiac Death donors, Journal of Hepatology, 2012, 56, 2, 474

    CrossRef

  11. 11
    Patricia Sheiner, Caroline Rochon, Recurrent Hepatitis C After Liver Transplantation, Mount Sinai Journal of Medicine: A Journal of Translational and Personalized Medicine, 2012, 79, 2
  12. 12
    Marina Berenguer, Ramón Charco, Juan Manuel Pascasio, Jose Ignacio Herrero, Spanish society of liver transplantation (SETH) consensus recommendations on hepatitis C virus and liver transplantation, Liver International, 2012, 32, 5
  13. 13
    Vijay Subramanian, Anil B. Seetharam, Neeta Vachharajani, Venkataswarup Tiriveedhi, Nataraju Angaswamy, Sabarinathan Ramachandran, Jeffrey S. Crippin, Surendra Shenoy, William C. Chapman, Thalachallour Mohanakumar, Christopher D. Anderson, Donor Graft Steatosis Influences Immunity to Hepatitis C Virus and Allograft Outcome After Liver Transplantation, Transplantation, 2011, 92, 11, 1259

    CrossRef

  14. 14
    R.S. de Fraga, P.E.T. Heinen, C.R.P. Kruel, S.D. Molin, S.M. Mota, C.T.S. Cerski, G. Gasperin, A.A. Souto, J.R. de Oliveira, M.R. Álvares-da-Silva, Fructose 1-6 Bisphosphate Versus University of Wisconsin Solution for Rat Liver Preservation: Does FBP Prevent Early Mitochondrial Injury?, Transplantation Proceedings, 2011, 43, 5, 1468

    CrossRef

  15. 15
    Roberto Hernandez-Alejandro, Kris P. Croome, Douglas Quan, Mohamed Mawardi, Natasha Chandok, Cheryl Dale, Vivian McAlister, Mark A. Levstik, William Wall, Paul Marotta, Increased Risk of Severe Recurrence of Hepatitis C Virus in Liver Transplant Recipients of Donation After Cardiac Death Allografts, Transplantation, 2011, 92, 6, 686

    CrossRef

  16. 16
    V.R. Camacho, R.S. Fraga, G.F. Souza, C.T. Cerski, J.R. Oliveira, M.G. Oliveira, M.R. Alvares-daSilva, Relationship Between Ischemia/Reperfusion Injury and the Stimulus of Fibrogenesis in an Experimental Model: Comparison Among Different Preservation Solutions, Transplantation Proceedings, 2011, 43, 10, 3634

    CrossRef

  17. 17
    Mohammad Mawardi, Faisal Aba Alkhail, Kazuhiro Katada, Mark Levstik, Douglas Quan, William Wall, Paul Marotta, Roberto HernandezAlejandro, The clinical consequences of utilizing donation after cardiac death liver grafts into hepatitis C recipients, Hepatology International, 2011, 5, 3, 830

    CrossRef

  18. 18
    Ran Tao, Kristine Ruppert, Ruy J. Cruz, Shahid M. Malik, Obaid Shaikh, Jawad Ahmad, Andrea DiMartini, Abhinav Humar, Paulo A. Fontes, Michael E. de Vera, Hepatitis C recurrence is not adversely affected by the use of donation after cardiac death liver allografts, Liver Transplantation, 2010, 16, 11
  19. 19
    Michael G. Hughes, Hugo R. Rosen, Human liver transplantation as a model to study hepatitis C virus pathogenesis, Liver Transplantation, 2009, 15, 11
  20. 20
    Geoffrey W. McCaughan, Nicholas A. Shackel, Patrick Bertolino, David G. Bowen, Molecular and Cellular Aspects of Hepatitis C Virus Reinfection After Liver Transplantation: How the Early Phase Impacts on Outcomes, Transplantation, 2009, 87, 8, 1105

    CrossRef

  21. 21
    Markus Selzner, Arash Kashfi, Nazia Selzner, Stuart McCluskey, Paul D. Greig, Mark S. Cattral, Gary A. Levy, Les Lilly, Eberhard L. Renner, George Therapondos, Lesley E. Adcock, David R. Grant, Ian D. McGilvray, Recipient age affects long-term outcome and hepatitis C recurrence in old donor livers following transplantation, Liver Transplantation, 2009, 15, 10
  22. 22
    Shin Hwang, Sung-Gyu Lee, Chul-Soo Ahn, Ki-Hun Kim, Deok-Bog Moon, Tae-Yong Ha, Gi-Won Song, Dong-Hwan Jung, Je-Ho Ryu, Kyung-Hoon Ko, Nam-Kyu Choi, Kwan-Woo Kim, Technique and outcome of autologous portal Y-graft interposition for anomalous right portal veins in living donor liver transplantation, Liver Transplantation, 2009, 15, 4
  23. 23
    M.T. Killackey, G.E. Gondolesi, L.U. Liu, A.S. Paramesh, S.N. Thung, A. Suriawinata, E. Nguyen, S. Roayaie, M.E. Schwartz, S. Emre, T.D. Schiano, Effect of Ischemia–Reperfusion on the Incidence of Acute Cellular Rejection and Timing of Histologic Hepatitis C Virus Recurrence After Liver Transplantation, Transplantation Proceedings, 2008, 40, 5, 1504

    CrossRef

  24. 24
    Kunj K. Desai, George S. Dikdan, Asif Shareef, Baburao Koneru, Ischemic preconditioning of the liver: A few perspectives from the bench to bedside translation, Liver Transplantation, 2008, 14, 11
  25. 25
    Marina Berenguer, Risk of extended criteria donors in hepatitis C virus–positive recipients, Liver Transplantation, 2008, 14, S2
  26. 26
    Michael Charlton, Approach to recurrent hepatitis C following liver transplantation, Current Gastroenterology Reports, 2007, 9, 1, 23

    CrossRef

  27. 27
    Jean F. Botha, Eric Thompson, Richard Gilroy, Wendy J. Grant, Sandeep Mukherjee, Elizabeth R. Lyden, Ira J Fox, Debra L. Sudan, Byers W. Shaw, Alan N. Langnas, Mild donor liver steatosis has no impact on hepatitis C virus fibrosis progression following liver transplantation, Liver International, 2007, 27, 6
  28. 28
    B. Roche, D. Samuel, Risk factors for hepatitis C recurrence after liver transplantation, Journal of Viral Hepatitis, 2007, 14,
  29. 29
    Rosângela Teixeira, Érica Godinho Menezes, Thomas D. Schiano, Therapeutic management of recurrent hepatitis C after liver transplantation, Liver International, 2007, 27, 3
  30. 30
    Martin F Sprinzl, Gerd Otto, Peter R Galle, Marcus Schuchmann, Hepatitis C virus re-infection: new perspectives, Clinical Transplantation, 2006, 20,
  31. 31
    Kymberly D.S. Watt, Elizabeth R. Lyden, James M. Gulizia, Timothy M. McCashland, Recurrent hepatitis C posttransplant: Early preservation injury may predict poor outcome, Liver Transplantation, 2006, 12, 1
  32. 32
    Grzegorz Nowak, Ulf G. Nor�n, Annika Wernerson, Hanns-Ulrich Marschall, Lennart M�ller, Bo-G�ran Ericzon, Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats, Transplant International, 2005,

    CrossRef

  33. 33
    N. R. Banga, S. Homer-Vanniasinkam, A. Graham, A. Al-Mukhtar, S. A. White, K. R. Prasad, Ischaemic preconditioning in transplantation and major resection of the liver, British Journal of Surgery, 2005, 92, 5
  34. 34
    Michal Carmiel-Haggai, M. Isabel Fiel, Himabindu C. Gaddipati, Chaim Abittan, Sabera Hossain, Sasan Roayaie, Myron E. Schwartz, Gabriel Gondolesi, Sukru Emre, Thomas D. Schiano, Recurrent hepatitis C after retransplantation: Factors affecting graft and patient outcome, Liver Transplantation, 2005, 11, 12
  35. 35
    Marina Berenguer, What determines the natural history of recurrent hepatitis C after liver transplantation?, Journal of Hepatology, 2005, 42, 4, 448

    CrossRef

  36. 36
    MICHAEL R. CHARLTON, K. V. NARAYANAN MENON, Transplantation of the Liver, 2005,

    CrossRef

  37. 37
    MARINA BERENGUER, JOHN LAKE, Transplantation of the Liver, 2005,

    CrossRef

  38. 38
    Victor I. Machicao, Hugo Bonatti, Murli Krishna, Bashar A. Aqel, Frank J. Lukens, Justin H. Nguyen, Barry G. Rosser, Raj Satyanarayana, Hani P. Grewal, Winston R. Hewitt, Denise M. Harnois, Julia E. Crook, Jeffery L. Steers, Rolland C. Dickson, Donor age affects fibrosis progression and graft survival after liver transplantation for hepatitis C1, Transplantation, 2004, 77, 1, 84

    CrossRef

  39. 39
    Grzegorz Nowak, Ulf G. Norén, Annika Wernerson, Hanns-Ulrich Marschall, Lennart Möller, Bo-Göran Ericzon, Enteral donor pre-treatment with ursodeoxycholic acid protects the liver against ischaemia-reperfusion injury in rats, Transplant International, 2004, 17, 12
  40. 40
    Steven B Porter, K.Rajender Reddy, Factors that influence the severity of recurrent hepatitis c virus following liver transplantation, Clinics in Liver Disease, 2003, 7, 3, 603

    CrossRef

  41. 41
    Michael Charlton, Natural history of hepatitis C and outcomes following liver transplantation, Clinics in Liver Disease, 2003, 7, 3, 585

    CrossRef

  42. 42
    Susan E. Chan, Hugo R. Rosen, Outcome and Management of Hepatitis C in Liver Transplant Recipients, Clinical Infectious Diseases, 2003, 37, 6, 807

    CrossRef

  43. 43
    Russell H. Wiesner, Jorge Rakela, Michael B. Ishitani, David C. Mulligan, James R. Spivey, Jeffery L. Steers, Ruud A.F. Krom, Recent Advances in Liver Transplantation, Mayo Clinic Proceedings, 2003, 78, 2, 197

    CrossRef

  44. 44
    PAUL J GOW, PETER W ANGUS, Disease recurrence after liver transplantation: Need we worry?, Journal of Gastroenterology and Hepatology, 2002, 17, 7
  45. 45
    M. Willems, H.J. Metselaar, H.W. Tilanus, S.W. Schalm, R.A. Man, Liver transplantation and hepatitis C, Transplant International, 2002, 15, 2-3
  46. 46
    Ergun Velidedeoglu, Niraj M. Desai, Louis Campos, Kim M. Olthoff, Abraham Shaked, Frederick Nunes, Gillian Zeldin, Charmaine Stewart, Emily Blumberg, John Abrams, James F. Markmann, The outcome of liver grafts procured from hepatitis C-positive donors, Transplantation, 2002, 73, 4, 582

    CrossRef

  47. 47
    Marina Berenguer, F.Xavier López-Labrador, Teresa L. Wright, Hepatitis C and liver transplantation, Journal of Hepatology, 2001, 35, 5, 666

    CrossRef

  48. 48
    Aijaz Ahmed, Emmet B. Keeffe, HEPATITIS C VIRUS AND LIVER TRANSPLANTATION, Clinics in Liver Disease, 2001, 5, 4, 1073

    CrossRef

  49. 49
    Andrew T. Chan, Raymond T. Chung, Hepatitis in the organ transplant patient, Current Opinion in Organ Transplantation, 2001, 6, 4, 295

    CrossRef

  50. 50
    Norah Terrault, Liver Transplantation in Patients with Hepatitis B, C or HIV Infection,